ArticleTranslational cancer research2025
Prediction of visceral pleural invasion of clinical stage IA lung adenocarcinoma based on computed tomography features.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- CT-based nomogram for estimating visceral pleural invasion in solid pulmonary adenocarcinoma nodules with pleural contact: a retrospective single-center study.BMC medical imaging · 2026Article
- CT predictors of visceral pleural invasion in subsolid nodular pulmonary adenocarcinoma: differences between direct and indirect tumor-pleura contact.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Observational
- 3D intratumoral heterogeneity-based quantitative score from chest CT for preoperative prediction of visceral pleural invasion in lung adenocarcinoma: a multicenter study.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In lung cancer, preoperative prediction of visceral pleural invasion (VPI) is helpful for choosing the best treatment plan and improving the prognosis of patients. This study aimed to investigate the usefulness of computed tomography (CT) features in predicting VPI in clinical stage IA peripheral lung adenocarcinoma (LUAD) with pleural contact. Methods: This study divided the type of contact between tumor and pleura into indirect and direct contacts. This study retrospectively analyzed patients with clinical stage IA peripheral LUAD in three hospitals and enrolled 485 patients. The CT features of lesions were analyzed to predict VPI, including relative pleural features, tumor signs, and characteristics between the tumor and pleura. Univariate and multivariate logistic regression analyses were used to select the best combination of variables to predict VPI, and the prediction models were developed. Results: The multivariate logistic regression analysis identified solid component size, pleural tag type, and vascular convergence sign to be independent risk factors for VPI in indirect pleural contact type. The area under curve (AUC) values of the model for predicting VPI in the training, internal validation, and external validation sets were 0.887, 0.799, and 0.862, respectively. Solid component size and pleural indentation sign were identified as independent risk factors for predicting VPI in direct pleural contact type. The AUC values of the model for predicting VPI in the training, internal validation, and external validation sets were 0.903, 0.848, and 0.842, respectively. Conclusions: CT predictors associated with VPI differ based on the type of contact with the pleura. The multivariate logistic regression models utilizing CT features demonstrates acceptable diagnostic accuracy in predicting VPI in clinical stage IA LUAD with pleural contact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.